# Peppermint Ibs Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/peppermint-ibs-meta-analysis-evidence-review
Category: evidence-review
Summary: Peppermint Ibs Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are guideline,
Last reviewed: 2026-05-28
Reviewed by: Migaku Evidence Review
# Peppermint Ibs Meta-analysis: What the Evidence Says

## Quick Answer

Peppermint Ibs Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are guideline, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 guideline.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines | guideline | 2 | 2026-01-06 | 10.3390/nu18020183 |

## What The Sources Report

- Young adults, particularly females, have a higher prevalence, which has increased substantially over the past decades. [Pastras Ploutarchos (2026); evidence level 2]
- More specifically, the presence of recurrent abdominal pain, on average, at least 1 day per week in the last 3 months, associated with two or more of the following: symptoms related to defecation, a change in stool frequency, or a change in stool form. [Pastras Ploutarchos (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For peppermint ibs meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Pastras Ploutarchos (2026). Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines. DOI: 10.3390/nu18020183. PMCID: PMC12845297. PMID: 41599795. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12845297/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.